GLYC logo

GlycoMimetics (GLYC) Cash From Financing

Annual CFF

$28.82 M
+$24.67 M+593.31%

December 31, 2023

Summary

Performance

1-Year Change

+593.31%

3-Year Change

+58.86%

5-Year Change

-77.73%

15-Year Change

-74.7%

GLYC Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.9%
GLYC annual cash flow from financing activities is higher than 71.9% of companies in Healthcare sector

High & Low

All-time High

$129.45 M
GLYC annual cash flow from financing activities is currently -77.73% below its historical high of $129.45 million

3-Year Low

$4.16 M
GLYC annual cash flow from financing activities is currently +593.31% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GLYC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
GLYC next annual earnings announcement is scheduled for Mar 27, 2025

OtherGLYCcash flowmetrics:

Annual CFI

-$21.40 K
GLYC annual cash flow from investing activities is -$21.40 thousand

Annual CFO

-$34.88 M
GLYC annual cash flow from operations is -$34.88 million

Annual FCF

-$34.90 M
GLYC annual free cash flow is -$34.90 million

Annual CAPEX

$21.40 K
GLYC annual capital expenditures is $21.40 thousand

Quarterly CFF

$0.00
-$500.00-100.00%

September 30, 2024

Summary

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

GLYC Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.03%
GLYC quarterly cash flow from financing activities is higher than 46.03% of companies in Healthcare sector

High & Low

All-time High

$128.93 M
GLYC quarterly cash flow from financing activities is currently -100.00% below its historical high of $128.93 million

3-Year Low

$0.00
GLYC quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GLYC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
GLYC next earnings announcement is scheduled for Mar 27, 2025

OtherGLYCcash flowmetrics:

Quarterly CFI

$0.00
GLYC quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$7.99 M
GLYC quarterly cash flow from operations is -$7.99 million

Quarterly FCF

-$7.99 M
GLYC quarterly free cash flow is -$7.99 million

Quarterly CAPEX

-
GLYC quarterly capital expenditures value is unknown

TTM CFF

$6400.00
-$61.60 K-90.59%

September 30, 2024

Summary

Performance

3-Month Change

-90.59%

1-Year Change

-99.98%

3-Year Change

-99.94%

5-Year Change

-99.94%

GLYC TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.59%
GLYC TTM cash flow from financing activities is higher than 26.59% of companies in Healthcare sector

High & Low

All-time High

$239.20 M
GLYC TTM cash flow from financing activities is currently -100.00% below its historical high of $239.20 million

3-Year Low

$6400.00
GLYC TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GLYC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
GLYC next earnings announcement is scheduled for Mar 27, 2025

OtherGLYCcash flowmetrics:

TTM CFI

-$10.70 K
GLYC TTM cash flow from investing activities is -$10.70 thousand

TTM CFO

-$35.01 M
GLYC TTM cash flow from operations is -$35.01 million

TTM FCF

-$35.02 M
GLYC TTM free cash flow is -$35.02 million

TTM CAPEX

-
GLYC TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GLYC Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+593.3%-100.0%-100.0%
3 y3 years+58.9%-100.0%-99.9%
5 y5 years-77.7%-100.0%-99.9%

GLYC Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+593.3%-100.0%at low-100.0%at low
5 y5-yearat high+6880.8%-100.0%at low-100.0%at low
alltimeall time-77.7%>+9999.0%-100.0%+100.0%-100.0%-100.0%

GlycoMimetics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(-100.0%)
$6400.00(-90.6%)
Jun 2024
-
$500.00(-89.8%)
$68.00 K(-22.4%)
Mar 2024
-
$4900.00(+390.0%)
$87.60 K(-99.7%)
Dec 2023
$28.82 M(+593.3%)
$1000.00(-98.4%)
$28.82 M(-12.6%)
Sep 2023
-
$61.60 K(+206.5%)
$32.98 M(+0.2%)
Jun 2023
-
$20.10 K(-99.9%)
$32.92 M(+0.1%)
Mar 2023
-
$28.74 M(+591.3%)
$32.90 M(+691.3%)
Dec 2022
$4.16 M(-61.2%)
$4.16 M(>+9900.0%)
$4.16 M(+264.8%)
Sep 2022
-
$0.00(0.0%)
$1.14 M(-1.8%)
Jun 2022
-
$0.00(0.0%)
$1.16 M(0.0%)
Mar 2022
-
$0.00(-100.0%)
$1.16 M(-89.2%)
Dec 2021
$10.72 M(-40.9%)
$1.14 M(+5378.8%)
$10.72 M(-20.4%)
Sep 2021
-
$20.80 K(>+9900.0%)
$13.47 M(-25.1%)
Jun 2021
-
$0.00(-100.0%)
$18.00 M(-34.7%)
Mar 2021
-
$9.56 M(+145.9%)
$27.58 M(+52.0%)
Dec 2020
$18.14 M(+4294.3%)
$3.89 M(-14.4%)
$18.14 M(+26.2%)
Sep 2020
-
$4.55 M(-52.6%)
$14.37 M(+43.5%)
Jun 2020
-
$9.58 M(+7269.0%)
$10.02 M(+1854.8%)
Mar 2020
-
$130.00 K(+8.5%)
$512.40 K(+24.1%)
Dec 2019
$412.90 K(-99.7%)
$119.80 K(-35.9%)
$413.00 K(-1.5%)
Sep 2019
-
$186.80 K(+146.4%)
$419.20 K(-43.1%)
Jun 2019
-
$75.80 K(+147.7%)
$737.20 K(+34.6%)
Mar 2019
-
$30.60 K(-75.7%)
$547.50 K(-99.6%)
Dec 2018
$129.45 M
$126.00 K(-75.0%)
$129.45 M(-13.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
$504.80 K(-543.2%)
$148.78 M(+0.3%)
Jun 2018
-
-$113.90 K(-100.1%)
$148.26 M(-38.0%)
Mar 2018
-
$128.93 M(+562.7%)
$239.20 M(+109.9%)
Dec 2017
$113.95 M(+381.3%)
$19.46 M(<-9900.0%)
$113.95 M(+19.1%)
Sep 2017
-
-$12.80 K(-100.0%)
$95.64 M(+0.1%)
Jun 2017
-
$90.83 M(+2372.6%)
$95.55 M(+266.5%)
Mar 2017
-
$3.67 M(+218.8%)
$26.07 M(+10.1%)
Dec 2016
$23.67 M(>+9900.0%)
$1.15 M(-1194.3%)
$23.67 M(+5.1%)
Sep 2016
-
-$105.30 K(-100.5%)
$22.53 M(-0.6%)
Jun 2016
-
$21.35 M(+1575.4%)
$22.65 M(+1624.7%)
Mar 2016
-
$1.27 M(>+9900.0%)
$1.31 M(+1050.0%)
Dec 2015
$114.10 K(-99.8%)
$3400.00(-83.2%)
$114.20 K(-2.4%)
Sep 2015
-
$20.20 K(+32.9%)
$117.00 K(+20.4%)
Jun 2015
-
$15.20 K(-79.8%)
$97.20 K(-51.8%)
Mar 2015
-
$75.40 K(+1116.1%)
$201.50 K(-99.6%)
Dec 2014
$57.38 M(>+9900.0%)
$6200.00(+1450.0%)
$57.38 M(-0.3%)
Sep 2014
-
$400.00(-99.7%)
$57.58 M(-0.6%)
Jun 2014
-
$119.50 K(-99.8%)
$57.92 M(+0.2%)
Mar 2014
-
$57.26 M(>+9900.0%)
$57.82 M(>+9900.0%)
Dec 2013
$558.90 K(>+9900.0%)
$199.10 K(-41.5%)
$559.00 K(+55.3%)
Sep 2013
-
$340.10 K(+1617.7%)
$359.90 K(+1717.7%)
Jun 2013
-
$19.80 K(>+9900.0%)
$19.80 K(>+9900.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
$200.00(-100.8%)
-
-
Dec 2011
-$24.20 K
-
-

FAQ

  • What is GlycoMimetics annual cash flow from financing activities?
  • What is the all time high annual CFF for GlycoMimetics?
  • What is GlycoMimetics annual CFF year-on-year change?
  • What is GlycoMimetics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for GlycoMimetics?
  • What is GlycoMimetics quarterly CFF year-on-year change?
  • What is GlycoMimetics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for GlycoMimetics?
  • What is GlycoMimetics TTM CFF year-on-year change?

What is GlycoMimetics annual cash flow from financing activities?

The current annual CFF of GLYC is $28.82 M

What is the all time high annual CFF for GlycoMimetics?

GlycoMimetics all-time high annual cash flow from financing activities is $129.45 M

What is GlycoMimetics annual CFF year-on-year change?

Over the past year, GLYC annual cash flow from financing activities has changed by +$24.67 M (+593.31%)

What is GlycoMimetics quarterly cash flow from financing activities?

The current quarterly CFF of GLYC is $0.00

What is the all time high quarterly CFF for GlycoMimetics?

GlycoMimetics all-time high quarterly cash flow from financing activities is $128.93 M

What is GlycoMimetics quarterly CFF year-on-year change?

Over the past year, GLYC quarterly cash flow from financing activities has changed by -$1000.00 (-100.00%)

What is GlycoMimetics TTM cash flow from financing activities?

The current TTM CFF of GLYC is $6400.00

What is the all time high TTM CFF for GlycoMimetics?

GlycoMimetics all-time high TTM cash flow from financing activities is $239.20 M

What is GlycoMimetics TTM CFF year-on-year change?

Over the past year, GLYC TTM cash flow from financing activities has changed by -$28.82 M (-99.98%)